Lithium treatment in patients with huntington disease and suicidal behavior

Journal of Clinical Psychopharmacology

Volumn 33, Issue 6, 2013, Pages 819-821

  Raja, Michele ^a   Soleti, Francesco ^b   Bentivoglio, Anna Rita ^b  

^a Centro Studi e Ricerche Gaetano Perusini   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMANTADINE; AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; LITHIUM; MIRTAZAPINE; OLANZAPINE; QUETIAPINE; TETRABENAZINE; VALPROIC ACID;

ADULT; AGED; AGGRESSIVENESS; AGITATION; BEDTIME DOSAGE; BRIEF PSYCHIATRIC RATING SCALE; CASE REPORT; DELUSION; DEPRESSION; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DSM-IV-TR; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HUNTINGTON CHOREA; LETTER; LITHIUM BLOOD LEVEL; MAJOR DEPRESSION; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; TREATMENT DURATION; UNIFIED HUNTINGTON DISEASE RATING SCALE;

ADULT; AGED; ANTIMANIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNTINGTON DISEASE; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SUICIDAL IDEATION; SUICIDE; TREATMENT OUTCOME;

EID: 84888136241     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31829c9748     Document Type: Letter

References (14)

1. Baliko L, Csala B, Czopf J. Suicide in Hungarian Huntington's disease patients. Neuroepidemiology. 2004;23:258-260.
2. Schoenfeld M, Myers RH, Cupples LA, et al. Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry. 1984;47:1283-1287.
3. Ventura J, Lukoff D, Nuechterlein KH, et al. Brief Psychiatric Rating Scale. Expanded Version 4.0. West Los Angeles VA Medical Center: UCLA Department of Psychiatry and Biobehavioral Sciences; 1993.
4. Baldessarini RJ, Pompili M, Tondo L. Suicide in bipolar disorder: risks and management. CNS Spectrums. 2006;11: 465-471.
5. Cipriani A, Pretty H, Hawton K, et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162:1805-1819.
6. Benazzi F, Koukopoulos A, Akiskal HS. Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur Psychiatry. 2004; 19:85-90.
7. Bonelli RM. Mirtazapine in suicidal Huntington disease. Ann Pharmacother. 2003;37(3):452.
8. Orth M, Handley OJ, Schwenke C, et al. The European Huntington's Disease Network. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY [Internet]. Version 19. PLoS Currents: Huntington Disease. 2010 [revised 2011 Apr 13]: PMC2947793.
9. Paulsen JS, Hoth KF, Nehl C, et al. Critical periods of suicide risk in Huntington's disease. Am J Psychiatry. 2005;162:725-731.
10. Akiskal HS, Benazzi F, Perugi G, et al. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressantsuicide controversy. J Affect Disord 2005; 85:245-258.
11. Van Putten T, Sanders DG. Lithium in treatment failures. J Nerv Ment Dis. 1975; 161:255-264.
12. Kenney C, Hunter C, Mejia N, et al. Is history of depression a contraindication to treatment with tetrabenazine? Clin Neuropharmacol. 2006;29:259-264.
13. Fergusson D, Doucette S, Glass KC, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials. Br Med J. 2005;330:396-399.
14. Gibbons RD, Brown CH, Hur K, et al. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am J Psychiatry. 2007;164:1044-1049.